BioCardia Announced The Primary Endpoint Results Of The Open Label Roll-in Cohort Of The Cardiamp Cell Therapy In Chronic Myocardial Ischemia Trial
BioCardia Announced The Primary Endpoint Results Of The Open Label Roll-in Cohort Of The Cardiamp Cell Therapy In Chronic Myocardial Ischemia Trial
BioCardia公佈了慢性心肌缺血試驗中Cardiamp細胞療法開放標籤滾入隊列的主要終點結果
BioCardia Announced The Primary Endpoint Results Of The Open Label Roll-in Cohort Of The Cardiamp Cell Therapy In Chronic Myocardial Ischemia Trial
BioCardia公佈了慢性心肌缺血試驗中Cardiamp細胞療法開放標籤滾入隊列的主要終點結果
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。